Mad Money Lightning Round OT: Cramer Likes CERN And XIDE, Dislikes MNKD

Jim Cramer said on CNBC's Mad Money Lightning Round OT that he can't recommend MannKind Corporation

, because it has some FDA hurdles ahead. He doesn't want to short it, but MNKD doesn't have a potential like some of the stocks he likes. MannKind (

) dropped 3.27% in today's trading session. Exide Technologies

is a good speculative stock, thinks Cramer. He likes it because its batteries are used by navy. Exide (

) fell 1.99% today. Cerner Corporation

was Cramer's second favorite stock in the space, after Allscripts-Misys Healthcare Solutions

. Currently, he likes Cerner Corporation (

) more, until we are through with the Misys separation with Allscripts.